Familial Exudative Vitreoretinopathy-Like Retinal Findings in Adams-Oliver Syndrome Type 2
- PMID: 40734490
- DOI: 10.1111/ceo.14594
Familial Exudative Vitreoretinopathy-Like Retinal Findings in Adams-Oliver Syndrome Type 2
Abstract
Background: This study investigated the clinical characteristics and the genotype-phenotype correlation of DOCK6-associated autosomal recessive Adams-Oliver Syndrome in a large cohort of familial exudative vitreoretinopathy patients.
Methods: Comprehensive ocular examinations were conducted on probands and their family members. Whole-exome sequencing (WES) was performed on the probands, with Sanger sequencing validation for family members. In vitro experiments validated copy number variation (CNV) and splice-site mutations.
Results: A total of 642 families with FEVR phenotypes were included, leading to the identification of seven probands with biallelic pathogenic DOCK6 mutations, corresponding to a prevalence of 1.09%. Thirteen mutation sites were identified, including seven frameshift mutations, four splice mutations, one CNV, and one nonsense mutation, indicating the pathogenic mechanism of DOCK6 in FEVR is more likely due to functional loss. Among the 14 eyes of the seven probands, five eyes (35.71%) and four eyes (28.57%) exhibited total retinal detachment and retinal folds, respectively.
Conclusions: Biallelic DOCK6 mutations represent a genetic cause of FEVR. These pathogenic mutations typically result in loss of function, leading to severe ocular and systemic manifestations. These findings highlight the importance of considering DOCK6 mutations in patients presenting with atypical or severe FEVR phenotypes.
Keywords: DOCK6; Adams‐Oliver syndrome; familial exudative vitreoretinopathy; genetics.
© 2025 Royal Australian and New Zealand College of Ophthalmologists.
References
-
- D. F. Gilmour, “Familial Exudative Vitreoretinopathy and Related Retinopathies,” Eye (London, England) 29 (2015): 1–14.
-
- Z. Tauqeer and Y. Yonekawa, “Familial Exudative Vitreoretinopathy: Pathophysiology, Diagnosis, and Management,” Asia‐Pacific Journal of Ophthalmology (Philadelphia, PA) 7 (2018): 176–182.
-
- J. Robitaille, M. L. MacDonald, A. Kaykas, et al., “Mutant Frizzled‐4 Disrupts Retinal Angiogenesis in Familial Exudative Vitreoretinopathy,” Nature Genetics 32 (2002): 326–330.
-
- J. A. Poulter, M. Ali, D. F. Gilmour, et al., “Mutations in TSPAN12 Cause Autosomal‐Dominant Familial Exudative Vitreoretinopathy,” American Journal of Human Genetics 98 (2016): 592.
-
- R. W. Collin, K. Nikopoulos, M. Dona, et al., “ZNF408 Is Mutated in Familial Exudative Vitreoretinopathy and Is Crucial for the Development of Zebrafish Retinal Vasculature,” Proceedings of the National Academy of Sciences of the United States of America 110 (2013): 9856–9861.
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
